|
Dear SPAGN Members and Friends,
the path to a correct diagnosis for sarcoma patients can be long and complex, with delays that can affect outcomes. To learn more about these challenges, SPAGN’s Global Survey on Sarcoma Diagnosis Pathways is capturing real-world patient experiences from around the world.
👀 Take a sneak peek at the data presented during CTOS 2024 below to learn more about the time to diagnosis and the occurence of misdiagnosis reported from 886 sarcoma patients worldwide.
All the best from the SPAGN Board of Directors & Team
PS. The survey is still open till December 31, 2024!
If you have not done so yet, please fill it out now, every feedback counts!
|